The Cell And Gene Therapy Supply Chain/Logistics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2024 has seen substantial growth in recent years. The market, which was valued at $1.41 billion in 2024, is predicted to reach $1.58 billion in 2025, expanding at a compound annual growth rate (CAGR) of 11.8%.
The cell and gene therapy supply chain/logistics market is projected to reach $2.44 billion by 2029, with a compound annual growth rate (CAGR) of 11.5%.
Download Your Free Sample of the 2025 Cell And Gene Therapy Supply Chain/Logistics Market Report and Uncover Key Trends Now!The key drivers in the cell and gene therapy supply chain/logistics market are:
• Expansion of personalized medicine and development of cell-free therapies
• Increased prevalence of chronic diseases
• Growth of the global cell therapy manufacturing market and efficient use of supply chain requirements
• Increase of research and development expenditure, adoption of advanced technologies, and favorable initiatives for easier access.
The cell and gene therapy supply chain/logistics market covered in this report is segmented –
1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System
2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution
3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components
4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up
5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization
The key trends in the cell and gene therapy supply chain/logistics market are:
• Increased research and development expenditure is shaping the future of the market.
• Adoption of innovative technologies is a significant emerging trend.
• Introduction of favorable initiatives and programs for easier access to therapies is an upcoming trend.
• Partnerships and collaborations among therapy companies, supply chain providers, and logistics companies are also influencing the market.
The major players in the cell and gene therapy supply chain/logistics market are:
• AmerisourceBergen Corporation
• United Parcel Service
• Thermo Fisher Scientific Inc
North America was the largest region in the cell and gene therapy supply chain/logistics market in 2024